Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

R

Rush University Medical Center

Other

0

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

0

Indications↗

Distinct diseases across all programs

147

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Evaluating Specific and Non-Specific Mechanisms in Two Distinct Complementary/Integrative Interventions for Chronic Pain

Evaluating Evidence Based Options for Initial PTSD Treatment Non-Responders

Automatic Tube Compensation vs. Pressure Support Ventilation During Spontaneous Breathing Trials in Critically Ill Adults: A Cluster-Randomized, Cluster-Crossover Trial

Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis

Earlier

Oct 16, 2026TrialE3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control

Oct 16, 2026TrialE3 Diabetes - Closing the Gap in Diabetes Control

Oct 9, 2026TrialOptimizing Effectiveness and Implementation of COPD Self-Management Treatment

Oct 3, 2026TrialThe Course of Hip Flexion Weakness Following LLIF or ALIF

3 more events

Oct 3, 2026TrialMIND Diet and Dementia Prevention in Ischemic Stroke Patients

Oct 2, 2026TrialCombating Health Disparities Using Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Failure in the Emergency Department

Oct 1, 2026TrialChronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis: A Randomized Crossover Trial

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)